NKTR logo

Nektar Therapeutics (NKTR) Long Term Debt

Annual Long Term Debt

$98.52 M
-$14.31 M-12.68%

31 December 2023

NKTR Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$86.76 M
-$4.00 M-4.41%

30 September 2024

NKTR Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NKTR Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.7%-15.1%
3 y3 years-27.8%-32.6%
5 y5 years-60.1%-77.9%

NKTR Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-27.8%at low-32.6%at low
5 y5 years-60.1%at low-77.9%at low
alltimeall time-77.5%>+9999.0%-80.2%>+9999.0%

Nektar Therapeutics Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$86.76 M(-4.4%)
June 2024
-
$90.76 M(-4.2%)
Mar 2024
-
$94.71 M(-3.9%)
Dec 2023
$98.52 M(-12.7%)
$98.52 M(-3.6%)
Sept 2023
-
$102.19 M(-3.4%)
June 2023
-
$105.82 M(-3.3%)
Mar 2023
-
$109.39 M(-3.0%)
Dec 2022
$112.83 M(-10.3%)
$112.83 M(-2.9%)
Sept 2022
-
$116.14 M(-2.7%)
June 2022
-
$119.42 M(-2.6%)
Mar 2022
-
$122.64 M(-2.5%)
Dec 2021
$125.74 M(-7.8%)
$125.74 M(-2.3%)
Sept 2021
-
$128.72 M(-2.2%)
June 2021
-
$131.66 M(-2.2%)
Mar 2021
-
$134.56 M(-1.3%)
Dec 2020
$136.37 M(-4.5%)
$136.37 M(-1.9%)
Sept 2020
-
$139.02 M(-1.8%)
June 2020
-
$141.63 M(-0.5%)
Mar 2020
-
$142.30 M(-0.3%)
Dec 2019
$142.73 M(-42.2%)
$142.73 M(-63.7%)
Sept 2019
-
$393.36 M(+14.8%)
June 2019
-
$342.64 M(+0.1%)
Mar 2019
-
$342.41 M(+38.7%)
Dec 2018
$246.95 M(+0.7%)
$246.95 M(+0.2%)
Sept 2018
-
$246.51 M(+0.2%)
June 2018
-
$246.08 M(+0.2%)
Mar 2018
-
$245.64 M(+0.2%)
Dec 2017
$245.21 M(+0.7%)
$245.21 M(+0.2%)
Sept 2017
-
$244.77 M(-0.3%)
June 2017
-
$245.39 M(-0.0%)
Mar 2017
-
$245.51 M(+0.8%)
Dec 2016
$243.46 M(+0.3%)
$243.46 M(-0.7%)
Sept 2016
-
$245.15 M(-0.1%)
June 2016
-
$245.32 M(-0.1%)
Mar 2016
-
$245.46 M(+1.1%)
Dec 2015
$242.77 M(+88.0%)
$242.77 M(>+9900.0%)
Sept 2015
-
$1.33 M(-99.0%)
June 2015
-
$127.89 M(-1.2%)
Mar 2015
-
$129.39 M(+0.2%)
Dec 2014
$129.14 M(-2.9%)
$129.14 M(-0.9%)
Sept 2014
-
$130.34 M(-0.5%)
June 2014
-
$131.03 M(-0.8%)
Mar 2014
-
$132.05 M(-0.8%)
Dec 2013
$133.05 M(-2.6%)
$133.05 M(-0.7%)
Sept 2013
-
$134.01 M(-0.7%)
June 2013
-
$134.90 M(-0.6%)
Mar 2013
-
$135.77 M(-0.6%)
Dec 2012
$136.61 M(+836.8%)
$136.61 M(-0.6%)
Sept 2012
-
$137.41 M(+943.1%)
June 2012
-
$13.17 M(-5.2%)
Mar 2012
-
$13.89 M(-4.7%)
Dec 2011
$14.58 M(-93.7%)
$14.58 M(-4.4%)
Sept 2011
-
$15.25 M(-93.4%)
June 2011
-
$230.82 M(-0.3%)
Mar 2011
-
$231.40 M(-0.2%)
Dec 2010
$231.97 M(-0.8%)
$231.97 M(-0.2%)
Sept 2010
-
$232.36 M(-0.2%)
June 2010
-
$232.84 M(-0.2%)
Mar 2010
-
$233.31 M(-0.2%)
Dec 2009
$233.75 M
$233.75 M(-0.2%)
Sept 2009
-
$234.18 M(-0.2%)
DateAnnualQuarterly
June 2009
-
$234.57 M(-0.2%)
Mar 2009
-
$234.94 M(-0.2%)
Dec 2008
$235.30 M(-30.1%)
$235.30 M(-29.9%)
Sept 2008
-
$335.69 M(-0.1%)
June 2008
-
$336.02 M(-0.1%)
Mar 2008
-
$336.33 M(-0.1%)
Dec 2007
$336.63 M(+0.6%)
$336.63 M(-0.1%)
Sept 2007
-
$336.99 M(+0.8%)
June 2007
-
$334.33 M(-0.1%)
Mar 2007
-
$334.55 M(-0.1%)
Dec 2006
$334.76 M(-23.6%)
$334.76 M(-16.6%)
Sept 2006
-
$401.44 M(-0.0%)
June 2006
-
$401.60 M(-0.0%)
Mar 2006
-
$401.76 M(-8.3%)
Dec 2005
$437.93 M(+121.7%)
$437.93 M(-0.0%)
Sept 2005
-
$438.07 M(+125.2%)
June 2005
-
$194.49 M(-0.1%)
Mar 2005
-
$194.60 M(-1.5%)
Dec 2004
$197.52 M(-49.6%)
$197.52 M(-0.1%)
Sept 2004
-
$197.70 M(-3.3%)
June 2004
-
$204.42 M(-3.9%)
Mar 2004
-
$212.78 M(-45.7%)
Dec 2003
$391.67 M(+18.3%)
$391.67 M(-6.6%)
Sept 2003
-
$419.19 M(+2.3%)
June 2003
-
$409.69 M(+23.9%)
Mar 2003
-
$330.64 M(-0.1%)
Dec 2002
$331.01 M(-0.0%)
$331.01 M(-0.1%)
Sept 2002
-
$331.49 M(+0.2%)
June 2002
-
$330.95 M(+0.0%)
Mar 2002
-
$330.82 M(-0.1%)
Dec 2001
$331.06 M(+3.7%)
$331.06 M(+0.7%)
Sept 2001
-
$328.76 M(+1.0%)
June 2001
-
$325.48 M(+2.4%)
Mar 2001
-
$317.94 M(-0.4%)
Dec 2000
$319.27 M(+181.7%)
$319.27 M(+31.6%)
Sept 2000
-
$242.63 M(-0.0%)
June 2000
-
$242.64 M(-0.8%)
Mar 2000
-
$244.65 M(+115.8%)
Dec 1999
$113.34 M(+2194.4%)
$113.34 M(+2211.3%)
Sept 1999
-
$4.90 M(-0.3%)
June 1999
-
$4.92 M(-0.2%)
Mar 1999
-
$4.92 M(-0.3%)
Dec 1998
$4.94 M(-3.2%)
$4.94 M(-0.3%)
Sept 1998
-
$4.96 M(-0.3%)
June 1998
-
$4.97 M(-2.2%)
Mar 1998
-
$5.09 M(-0.3%)
Dec 1997
$5.10 M(+2451.0%)
$5.10 M(+3347.3%)
Sept 1997
-
$148.00 K(-8.6%)
June 1997
-
$162.00 K(-7.4%)
Mar 1997
-
$175.00 K(-12.5%)
Dec 1996
$200.00 K(-50.0%)
$200.00 K(0.0%)
Sept 1996
-
$200.00 K(-33.3%)
June 1996
-
$300.00 K(0.0%)
Mar 1996
-
$300.00 K(-25.0%)
Dec 1995
$400.00 K(-20.0%)
$400.00 K(+33.3%)
Sept 1995
-
$300.00 K(0.0%)
June 1995
-
$300.00 K(-25.0%)
Mar 1995
-
$400.00 K(-20.0%)
Dec 1994
$500.00 K
$500.00 K(-16.7%)
June 1994
-
$600.00 K(0.0%)
Mar 1994
-
$600.00 K

FAQ

  • What is Nektar Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Nektar Therapeutics?
  • What is Nektar Therapeutics annual long term debt year-on-year change?
  • What is Nektar Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly long term debt year-on-year change?

What is Nektar Therapeutics annual long term debt?

The current annual long term debt of NKTR is $98.52 M

What is the all time high annual long term debt for Nektar Therapeutics?

Nektar Therapeutics all-time high annual long term debt is $437.93 M

What is Nektar Therapeutics annual long term debt year-on-year change?

Over the past year, NKTR annual long term debt has changed by -$14.31 M (-12.68%)

What is Nektar Therapeutics quarterly long term debt?

The current quarterly long term debt of NKTR is $86.76 M

What is the all time high quarterly long term debt for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly long term debt is $438.07 M

What is Nektar Therapeutics quarterly long term debt year-on-year change?

Over the past year, NKTR quarterly long term debt has changed by -$15.44 M (-15.10%)